GR

Grandomics

Beijing, CN · 3 known investors

grandomics.com ↗

Grandomics (希望组), founded in 2011, provides third-generation (long-read) sequencing services and big-data analysis for research institutions, clinical diagnostics, and bioinformatics. The company develops its own genome assembly and variant-analysis software and operates sequencing platforms and medical testing labs in Beijing and Wuhan, China.

Investors · 3

MA

Matrix Partners China✓ verifiedBeijing · $1.6M – $113M

VI

Vitalbridge Capital✓ verifiedGrand Cayman

MA

Marathon Venture Partners